Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma
Metrics: PDF 1325 views | HTML 1790 views | ?
Wenzhi Guo1, Jiakai Zhang1, Dongyu Zhang2, Shengli Cao1, Gongquan Li1, Shuijun Zhang1, Zhihui Wang1, Peihao Wen1, Han Yang1, Xiaoyi Shi1, Jie Pan1 and Hua Ye3
1Department of Hepatic and Biliary Pancreatic Surgery, Henan Key Laboratory of Digestive Organ Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China
2Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China
3College of Public Health, Zhengzhou University, Zhengzhou, Henan, P.R. China
Wenzhi Guo, email: email@example.com
Hua Ye, email: firstname.lastname@example.org
Keywords: circ-ITCH, hepatocellular carcinoma, susceptibility, survival
Received: March 20, 2017 Accepted: May 01, 2017 Published: June 01, 2017
Hepatocellular carcinoma (HCC) ranks the sixth most common cancer and the third cause of cancer-related mortality worldwide. Recent studies identified that circ-ITCH Suppresses mutiple cancers proliferation via inhibiting the Wnt/beta-Catenin pathway. In current study, conducted a genetic association study together with epidemiological follow-up study to delineate the role of circ-ITCH in the development and progression of HCC. we found rs10485505 (adjusted OR =1.18; 95% CI=1.06-1.31; P value =3.1×10-3) and rs4911154 (adjusted OR =1.27; 95% CI=1.14-1.43; P value =3.7×10-5) were significantly associated with increased HCC risk. The expression level of circ-ITCH was significantly lower in HCC tissues, compared with that in adjacent tissues (P value < 0.001). Cox regression analysis indicated that high expression of circ-ITCH was associated with favorable survival of HCC (HR=0.45; 95% CI=0.29-0.68; P value < 0.001). These results indicate that circ-ITCH may have an inhibitory effect on HCC, and could serve as susceptibility and prognostic biomarkers for HCC patients.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.